Non-Alcoholic Fatty Liver Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have been diagnosed with a long-term (chronic) liver condition confirmed by a tissue sample, including fatty liver disease (NAFLD), alcohol-related liver disease, hepatitis B or C, or liver conditions caused by genetic or autoimmune conditions (such as Wilson disease or hemochromatosis)
- People who have sudden (acute) liver inflammation or reduced blood flow to the liver caused by a heart condition, as determined by blood tests, scans, and medical history
- People who are able to understand the study and agree in writing to take part
Who may not be able to join:
- People who have a medical implant in their body, such as a pacemaker, implanted pump, or hip replacement
- People who have metal objects inside their body, such as metal fragments from an accident
- People who have had brain or heart surgery
- People who experience fear of enclosed spaces (claustrophobia)
- People who weigh more than 140kg (or above the limit set by the MRI machine being used)
- Women who are pregnant or breastfeeding
- People who currently have active liver cancer (though people who previously had liver cancer and received curative treatment may still be considered)
- People with severe (Child C) liver cirrhosis
- People with significant fluid build-up in the abdomen (ascites), unless it has cleared up with medication
- People with metabolic syndrome or a body mass index (BMI) above 30 kg/m² (confirm with trial site for which group this applies to)
- People who already have an acute or chronic liver disease (confirm with trial site for which group this applies to)
- People who are unwilling or unable to provide written consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Magdalena Filipowicz Sinnreich, PD Dr., University Hospital of Basel
Phone: 0613287789
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the spatial-temporal deformation fields
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.